WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…
Company Announcement COPENHAGEN, Denmark; June 18, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,986 shares…
Breast cancer patients in Switzerland will receive access to a personalized digital therapeutic designed to optimize their experience and health…
MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with…
The Successful Briefing Addressed Insurance Coverage for Oral Anticancer MedicationsWASHINGTON, June 18, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation-led…
ESSILORLUXOTTICA AND DIESELANNOUNCE A TEN-YEAR LICENSING AGREEMENT Charenton-le-Pont, France and Milan, Italy (18 June 2024) – EssilorLuxottica and Diesel announced…
Roots for Resilience to engage with small, rural and Indigenous communitiesOTTAWA, June 18, 2024 (GLOBE NEWSWIRE) -- The Canadian Red…
Aggregated presentation by day and by market Purchases of own shares from June 10th to 14th 2024 Name of the IssuerIdentity…
Press release Ecully, June 18, 2024 – 6 p.m. Presentation of the KAPHORN system to 200 surgeonsat the SOTCOT Congress in Hammamet…
Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha TherapyAUSTIN, Texas, June…